Biblio
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts. Int J Hematol. 2023.
Clinical benefit of low-dose anti-thymocyte globulin-thymoglobulin as a graft-versus-host disease prophylaxis in patients receiving allogeneic peripheral blood stem cell transplantation from human leukocyte antigen-identical donors. Transplant Cell Ther. 2023.
Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma. Front Pediatr. 2023;11:1305657.
.